Parkinson Disease

Parkinson disease is diagnosed clinically. Establish parkinsonism by documenting bradykinesia with either rigidity or rest tremor; the Movement Disorder Society definition does not require postural instability. During repetitive movements, distinguish true bradykinesia by progressive decrement in amplitude or speed rather than generalized slowness alone. BMJ+3BMJParkinson disease - Symptoms, diagnosis and treatment | BMJ Best Practice USPubMedClinical Aspects of the Differential Diagnosis of Parkinson’s Disease and ParkinsonismPubMedDefining Parkinson’s Disease: Past and FuturePubMedTable 1, The clinical diagnostic criteria for Parkinson’s disease, based on the Movement Disorder Society guidelines - Parkinson’s Disease - NCBI Bookshelf

After confirming parkinsonism, obtain a medication history that specifically identifies dopamine receptor blockers and dopamine-depleting agents. Parkinsonism temporally compatible with these exposures is an MDS absolute exclusion criterion for PD and should prompt a drug-induced parkinsonism pathway rather than empiric diagnostic labeling. PubMedPubMedTable 1, The clinical diagnostic criteria for Parkinson’s disease, based on the Movement Disorder Society guidelines - Parkinson’s Disease - NCBI Bookshelf

Record laterality, limb rest tremor, progression, and nonmotor symptoms at baseline. Persistent asymmetry, rest tremor, a progressive course, and a good levodopa response support idiopathic PD, but no early biomarker definitively establishes PD or reliably separates it from all neurodegenerative mimics. PubMed+1PubMedDefining Parkinson’s Disease: Past and FuturePubMed1.2 Clinical presentation and diagnosis of Parkinson's disease - Where are We? Continuous Dopaminergic Stimulation for Parkinson's Disease - NCBI Bookshelf

Actively query the tempo of gait failure, falls, autonomic dysfunction, dysphagia, dysarthria, stridor, cognitive-language syndrome, and ocular motor symptoms. Rapid gait progression to wheelchair dependence within 5 years, recurrent balance-related falls within 3 years, severe autonomic failure within 5 years, early bulbar dysfunction, inspiratory respiratory dysfunction, and disproportionate anterocollis or contractures are MDS red flags. PubMedPubMedTable 1, The clinical diagnostic criteria for Parkinson’s disease, based on the Movement Disorder Society guidelines - Parkinson’s Disease - NCBI Bookshelf

Examine for cerebellar signs, vertical supranuclear gaze palsy, cortical sensory loss, ideomotor apraxia, and progressive aphasia. These findings are exclusion criteria because they favor alternative neurodegenerative diagnoses such as multiple system atrophy, progressive supranuclear palsy, or corticobasal syndrome rather than idiopathic PD. PubMed+1PubMedTable 1, The clinical diagnostic criteria for Parkinson’s disease, based on the Movement Disorder Society guidelines - Parkinson’s Disease - NCBI BookshelfPubMedDiagnosis and Differential Diagnosis of Parkinson Disease

Use longitudinal levodopa responsiveness diagnostically. A gratifying response to an adequate dopaminergic trial supports PD; no response to high-dose levodopa in at least moderate disease is an exclusion criterion. Conversely, some patients with vascular parkinsonism obtain levodopa benefit, so a levodopa trial remains appropriate when vascular parkinsonism is suspected. PubMed+2PubMedTable 1, The clinical diagnostic criteria for Parkinson’s disease, based on the Movement Disorder Society guidelines - Parkinson’s Disease - NCBI BookshelfPubMedThe Differential Diagnosis of Parkinson's Disease - NCBIPubMed1.2 Clinical presentation and diagnosis of Parkinson's disease - Where are We? Continuous Dopaminergic Stimulation for Parkinson's Disease - NCBI Bookshelf

Oral levodopa remains the most effective and widely used treatment for PD motor symptoms. Select therapy according to functional disability, motor phenotype, adverse-effect vulnerability, current medications, and nonmotor burden rather than treating imaging or diagnostic certainty alone. BMJ+1BMJParkinson disease - Symptoms, diagnosis and treatment | BMJ Best Practice USWileyUpdate on the Management of Parkinson's Disease for ...

A meaningful dopaminergic response is both therapeutic and diagnostically supportive. Document the target symptom, functional change, timing of benefit, adverse effects, and whether dyskinesia emerges; levodopa-induced dyskinesia is a supportive feature for PD in MDS criteria. PubMed+2PubMedDefining Parkinson’s Disease: Past and FuturePubMedTable 1, The clinical diagnostic criteria for Parkinson’s disease, based on the Movement Disorder Society guidelines - Parkinson’s Disease - NCBI BookshelfPubMed1.2 Clinical presentation and diagnosis of Parkinson's disease - Where are We? Continuous Dopaminergic Stimulation for Parkinson's Disease - NCBI Bookshelf

For wearing-off or dyskinesia, identify the relationship of symptoms to individual levodopa doses before adding therapy. Reviews of motor-complication management address catechol-O-methyltransferase inhibitors, selective MAO-B inhibitors, istradefylline, amantadine formulations, clozapine, and device-assisted medication therapies; choice requires phenotype-specific assessment rather than a uniform escalation sequence. Wiley+1WileyInternational Parkinson and movement disorder society ...ScienceDirectMedical Management and Prevention of Motor Complications in Parkinson's Disease

Do not restrict follow-up to tremor, rigidity, gait, or medication timing. Nonmotor symptoms are integral to PD, can be prominent during the premotor phase, and substantially influence quality of life, hospital use, and care costs. Use structured questioning for sleep, mood, cognition, autonomic symptoms, fatigue, pain, psychosis, and impulse-control behaviors at routine reviews. BMJ+1BMJNon-motor Parkinson's: integral to motor Parkinson's, yet often neglected | Practical NeurologyWileyUpdate on treatments for nonmotor symptoms of Parkinson's ...

When cognitive decline is suspected, bedside assessment should include visuospatial and executive tasks. A clock-drawing exercise can reveal visuospatial-executive impairment but does not replace formal neuropsychological testing. Relatively preserved episodic memory with improved recall after prompting supports executive retrieval failure described in DLB, whereas impaired recall and recognition suggest medial temporal dysfunction. BMJBMJDementia with Lewy bodies: a practical guide to clinical diagnosis and management | Practical Neurology

Assess orthostatic symptoms and medication-associated hypotension whenever levodopa formulations are combined with selective MAO-B inhibitors. Clarify daytime sleepiness and sudden sleep episodes before driving or safety-sensitive activity, particularly with carbidopa/levodopa extended-release capsules. dailymed nlm nihdailymed nlm nihThese highlights do not include all the information needed to use CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES. CARBIDOPA and LEVODOPA extended-release capsules, for oral use Initial U.S. Approval: 1975

Revisit diagnostic certainty when red flags accumulate, levodopa response is absent or unexpectedly weak, or the syndrome becomes rapidly symmetric, axial, autonomic, bulbar, ocular motor, cerebellar, cortical, or cognitive-language predominant. MDS probable PD permits only up to two red flags, each counterbalanced by supportive criteria; clinically established PD permits none. PubMed+1PubMedDefining Parkinson’s Disease: Past and FuturePubMedTable 1, The clinical diagnostic criteria for Parkinson’s disease, based on the Movement Disorder Society guidelines - Parkinson’s Disease - NCBI Bookshelf

An abnormal presynaptic dopaminergic study is not synonymous with idiopathic PD, and normal presynaptic dopaminergic imaging is an MDS exclusion criterion. In suspected vascular parkinsonism, DaTSCAN is usually normal but can be abnormal after focal basal-ganglia infarction; interpret imaging within the clinical and structural-imaging context. PubMed+1PubMedTable 1, The clinical diagnostic criteria for Parkinson’s disease, based on the Movement Disorder Society guidelines - Parkinson’s Disease - NCBI BookshelfPubMedThe Differential Diagnosis of Parkinson's Disease - NCBI

Refer early to a movement-disorders specialist when the phenotype is atypical, the diagnosis remains uncertain, motor complications become difficult to control, or functional-neurosurgical therapy is contemplated. Multidisciplinary care is central to personalized PD management because motor and nonmotor disability require coordinated treatment planning. BMJ+1BMJParkinson disease - Symptoms, diagnosis and treatment | BMJ Best Practice USScienceDirectSurgical Treatment of Parkinson's Disease: Devices and ...